This award will enable Dr. Fujimoto's lab to move beyond structural imaging of the eye to develop and demonstrate functional optical coherence tomography.
Obtaining the Category III CPT code for OCT of the skin is an important step towards our goal of obtaining reimbursement and coverage, and we welcome the new codes that can be used by clinicians to record their clinical use of VivoSight OCT in their practice.
We showed that you can take effectively any OCT system out there and, with minimal changes, boost its resolution to the point where it can detect anatomical features smaller than the size of a typical cell.
We're close to an easy-to-use, handheld optical coherence tomography (OCT) device for the operating room, but it still needs to be cheaper, lighter, and able to adapt to eye changes in the first 3 years of life.
The NSF Graduate Research Fellowship is extremely competitive, and receiving this number of awards testifies to the high quality of our graduate student body in general and to the promise of these students in particular.
This honor highlights the commitment Avinger has to bring the most advanced technology to market for physicians dedicated to treating PAD and their patients who are affected by this disease...Pantheris radically changes the treatment of vascular disease and the Edison Award represents a win for our entire Lumivascular portfolio.
While we have been actively advancing our lesion assessment technology for the last two years, we are very pleased to see that the significant Series B investment will give MedLumics the means to complete our best-in-class product, conduct a series of international clinical trials to prove its safety and efficacy, and market it to specialist centers. As the company advances and grows into new areas, we will now expand and develop the team internationally.
